20626 ⎘
Medicinal preparations containing materials or reaction products thereof with undetermined constitution; Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells Fibroblasts
PREVENTION AND TREATMENT OF KIDNEY FAILURE BY ADMINISTRATION OF FIBROBLASTS AND PRODUCTS THEREOF
#2FIBROBLAST CELL THERAPY FOR TREATMENT OF OSTEOPOROSIS
#3ADHESION MOLECULE INHIBITION FOR STEM CELL THERAPIES
#4ENHANCEMENT OF FIBROBLAST PLASTICITY FOR TREATMENT OF DISC DEGENERATION
#5TREATMENT OF CEREBRAL PALSY USING FIBROBLASTS
#6COMPOSITIONS AND METHODS FOR TREATMENT OF TRAUMATIC BRAIN INJURY (TBI), FOR EXAMPLE, MILD TRAUMATIC BRAIN INJURY (mTBI)
#7POROUS HYDROGEL MICROSPHERES AND PREPARATION METHODS THEREOF
#8POROUS HYDROGEL MICROSPHERES AND PREPARATION METHODS THEREOF
#9PROCESS FOR PREPARING METABOLIZED CONDITIONED GROWTH MEDIA
#10MAMMALIAN CELL POPULATION AND MENDICAMENTS FOR CELL THERAPIES IN EQUINES AND IMPROVED CELL CULTIVATION METHODS
#11MAMMALIAN CELL POPULATION AND MEDICAMENTS FOR CELL THERAPIES IN DOMESTIC ANIMALS AND IMPROVED CELL CULTIVATION METHODS
#12CELL-DERIVED PARTICLES PRESENTING HETEROLOGOUS CD24 AND USE THEREOF IN THERAPY
#13MAMMALIAN CELL POPULATION AND MEDICAMENTS FOR CELL THERAPIES IN HUMANS AND IMPROVED CELL CULTIVATION METHODS
#14HUMAN TISSUE DERIVED COMPOSITIONS AND USES THEREOF
#15THERAPEUTIC USE OF FIBROBLASTS TO STIMULATE REGENERATION AND REPAIR OF ATROPHIED SPLEEN
#16INTERACTION OF FIBROBLASTS AND IMMUNE CELLS FOR ACTIVATION AND USES THEREOF
#17METHODS AND COMPOSITIONS RELATING TO CHONDRISOMES FROM BLOOD PRODUCTS
#18METHODS AND COMPOSITIONS HIGH SCALE THERAPEUTIC PRODUCTION OF MEMORY NK CELLS
#19THERAPEUTIC USE OF CANCER-ASSOCIATED FIBROBLAST-ENCAPSULATED PANCREATIC BETA CELLS FOR TREATING DIABETES
#20THERAPEUTIC USE OF FIBROBLASTS TO STIMULATE THE IMMUNE SYSTEM
#21TREATMENT OF OPIOID ADDICTION USING FIBROBLASTS AND PRODUCTS THEREOF
#22FIBROBLAST THERAPY FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
#23METHODS OF EDITING DNA METHYLATION
#24METHOD AND APPARATUS FOR STIMULATION OF CELLS FOR TISSUE REPAIR
#25CONDITIONED MEDIUM FROM CELLS CULTURED UNDER HYPOXIC CONDITIONS AND USES THEREOF
#26METHODS AND COMPOSITIONS RELATING TO CHONDRISOMES FROM CULTURED CELLS
#27METHODS FOR MODULATING THE REGENERATIVE PHENOTYPE IN MAMMALIAN CELLS
#28FIBROBLAST-CONTAINING PHARMACEUTICAL COMPOSITION FOR TREATING KIDNEY DISEASE
#29Mammalian cell population and medicaments for cell therapies in humans and improved cell cultivation methods
#30Mammalian cell population and medicaments for cell therapies in canines and improved cell cultivation methods
#31MAMMALIAN CELL POPULATION AND MEDICAMENTS FOR CELL THERAPIES IN EQUINES AND IMPROVED CELL CULTIVATION METHODS
#32LIQUID DELIVERY COMPOSITION
#33FIBROBLAST DELIVERY OF TUMOR INHIBITORY AGENTS
#34FIBROBLAST DELIVERY OF TUMOR INHIBITORY AGENTS
#35STIMULATION OF ANGIOGENESIS BY FIBROBLAST DERIVED EXOSOMES
#36FIBROBLAST BASED THERAPEUTICS OF AMYOTROPHIC LATERAL SCLEROSIS
#37MULTILAYERED BLOOD PRODUCT
#38SYSTEMS, DEVICES AND METHODS FOR THE CREATION OF A THERAPEUTIC RESTRICTION IN THE GASTROINTESTINAL TRACT
#39TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND LUNG DEGENERATION USING ACTIVATED FIBROBLASTS AND EXOSOME DERIVATIVES THEREOF
#40METHODS FOR PRIMING ALLOGENEIC CULTURED KERATINOCYTE COMPOSITIONS FOR TOPICAL USE
#41LYMPHANGIOGENESIS PROMOTING FACTOR-EXPRESSING FIBROBLAST, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
#42METHODS AND COMPOSITIONS FOR ALOPECIA TREATMENT USING FIBROBLASTS AND FIBROBLAST-DERIVED PRODUCTS
#43METHODS FOR THE PRODUCTION OF CARDIAC FIBROBLASTS
#44Use of an intervertebral disc fibrosis-inducing substance in preparation of medication
#45PREPARATION AND THERAPEUTIC USE OF 3D-CULTURED FIBROBLASTS
#46FAT-ASSOCIATED LYMPHOID CLUSTERS AS SITES FOR TRANSPLANTATION, TISSUE REGENERATION, ORGANOGENESIS AND FUNCTION FOR MULTIPLE TISSUES
#47CELL SHEET FOR GENE DELIVERY
#48ANTI-CANCER-ASSOCIATED NON-TUMOR CELL AGENT COMPRISING VIRUS
#49Mitochondria-Enriched Extracellular Vesicles
#50ISOLATED PRIMARY DERMAL FIBROBLASTS FOR TREATING SKIN CONDITIONS
#51METHODS AND COMPOSITIONS FOR ALLERGY AND ASTHMA TREATMENT USING FIBROBLASTS
#52PLACENTAL TISSUE GRAFTS AND IMPROVED METHODS OF PREPARING AND USING THE SAME
#53COMBINATION OF KYNURENINE AND ANTIGEN PRESENTING CELLS (APC) AS THERAPEUTICS AND METHODS FOR THEIR USE IN IMMUNE MODULATION
#54DE-DIFFERENTIATED FIBROBLAST-CONDITIONED MEDIA FOR STIMULATION OF DISC REGENERATION
#55TREATMENT OF DISC DEGENERATIVE DISEASE AND STIMULATION OF PROTEOGLYCAN SYNTHESIS BY FIBROBLAST CONDITIONED MEDIA AND FORMULATIONS THEREOF
#56GENERATION OF THERAPEUTIC CELLS USING EXTRACELLULAR COMPONENTS OF TARGET ORGANS
#57FIBROBLAST AND TLR ACTIVATED FIBROBLAST TREATMENT OF VIRAL INDUCED ACUTE RESPIRATORY DISTRESS SYNDROME
#58METHODS AND COMPOSITIONS FOR REPAIR OF CARTILAGE USING AN IN VIVO BIOREACTOR
#59DENTAL AND PERIODONTAL APPLICATION OF FIBROBLASTS
#60METHODS FOR NUCLEAR REPROGRAMMING USING SYNTHETIC TRANSCRIPTION FACTORS
#61PROGRAMMED CELLS FOR TARGETED ARTICULAR CARTILAGE AND BONE REGENERATION
#62THERAPEUTIC USE OF FIBROBLASTS FOR USE IN WOUND HEALING
#63SKIN-DERIVED FIBROBLAST EXHIBITING TENDON REGENERATION EFFECT AND USE THEREOF
#64Dosage Unit Formulations Of Autologous Dermal Fibroblasts
#65REDUCTION OF COVID-19 COAGULOPATHY AND OTHER INFLAMMATION-ASSOCIATED COAGULOPATHIES BY ADMINISTRATION OF FIBROBLASTS
#66AUGMENTATION OF FIBROBLAST CELL THERAPY EFFICACY BY MICROBIOME MANIPULATION
#67FIBROBLAST BASED THERAPY FOR TREATMENT OF PARKINSON'S DISEASE
#68CELL-DERIVED PARTICLES PRESENTING HETEROLOGOUS CD24 AND USE THEREOF IN THERAPY
#69METHODS OF USING ZSCAN4 FOR REJUVENATING HUMAN CELLS
#70FIBROBLASTS AS A REGENERATIVE CELLULAR SOURCE FOR THE TREATMENT OF BLINDNESS
#71AUGMENTATION OF FIBROBLAST THERAPY USING EXTRACORPOREAL SHOCK WAVE THERAPY AND/OR TRANSFECTION OF BIOLOGICALLY RELEVANT MOLECULES
#72EXOSOME-DERIVED PIWI-INTERACTING RNA AND METHODS OF USE THEREOF
#73FIBROBLAST THERAPY FOR PREVENTION AND REVERSION OF ANEURYSMS
#74TREATMENT OF FRONTOTEMPORAL DEMENTIA USING FIBROBLASTS AND PRODUCTS THEREOF
#75Electrospun fibrous matrix, its preparation method and uses thereof
#76GENE MODIFIED FIBROBLASTS FOR THERAPEUTIC APPLICATIONS
#77COMPOSITIONS AND METHODS CONTAINING EXOSOMES
#78TREATMENT OF OVARIAN FAILURE USING REGENERATIVE CELLS
#79Membrane-type metalloprotease inhibitory protein and pharmaceutical and pharmaceutical composition containing same, and respective uses thereof
#80HORMONAL MANIPULATION OF FIBROBLAST THERAPEUTIC ACTIVITY
#81TREATMENT OF AUTOIMMUNITY AND TRANSPLANT REJECTION THROUGH ESTABLISHMENT AND/OR PROMOTION OF TOLEROGENIC PROCESSES BY FIBROBLAST-MEDIATED REPROGRAMMING OF ANTIGEN PRESENTING CELLS
#82FIBROBLAST MEDIATED EXPANSION AND AUGMENTATION OF IMMUNE REGULATORY CELLS FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)
#83Methods to improve cell therapy
#84PEPTIDES AND ADJUVANTS FOR AUGMENTATION OF FIBROBLAST THERAPY FOR CORONAVIRUS
#85BIOMATERIAL COMPRISING A RESORBABLE POROUS MATRIX AND ASSOCIATED MANUFACTURING METHOD
#86TREATMENT OF CEREBRAL PALSY USING FIBROBLASTS
#87Methods of editing DNA methylation
#88TELOMERE LENGTH MODULATION USING FIBROBLASTS
#89METHODS OF MANUFACTURING EXTRACELLULAR MATRIX USING ASPARTYL ALANYL DIKETOPIPERAZINE (DA-DKP)
#90ENGINEERED FIBROBLASTS AS CELL THERAPY TO TREAT CANCER VIA TUMOR STROMA STABILIZATION
#91HUMAN TISSUE DERIVED COMPOSITIONS AND USES THEREOF
#92SUPPRESSION OF INTERLEUKIN-17 PRODUCTION AND INHIBITION OF TH17 CELL GENERATION BY FIBROBLASTS AND PRODUCTS THEREOF
#93INHIBITION OF TNF-ALPHA BY FIBROBLASTS AND FIBROBLAST EXOSOMES
#94CANNABIDIOL ADJUVANT THERAPY FOR TREATMENT OF DISC DEGENERATIVE DISEASE
#95FIBROBLAST-BASED THERAPY FOR TREATMENT AND PREVENTION OF STROKE
#96FIBROBLAST THERAPY FOR INFLAMMATORY BOWEL DISEASE
#97FIBROBLAST-DERIVED UNIVERSAL IMMUNOLOGICAL COMPOSITION
#98MEANS FOR USE IN PREPARATION OF HYDROGEL BASED ON HYDROXYPHENYL DERIVATIVE OF HYALURONAN, METHOD OF HYDROGEL PREPARATION AND USE THEREOF
#99FIBROBLAST-BASED THERAPY FOR TREATMENT OF SCLEROSING CHOLANGITIS
#100MODIFIED CELLS AND RELATED METHODS
#101AUGMENTATION OF FIBROBLAST MEDIATED REGENERATION OF INTRAVERTEBRAL DISCS
#102PREVENTION AND TREATMENT OF KIDNEY FAILURE BY ADMINISTRATION OF FIBROBLASTS AND PRODUCTS THEREOF
#103INDUCTION OF TUMOR VASCULAR NECROSIS UTILIZING FIBROBLASTS
#104FIBROBLAST AND FIBROBLAST-IMMUNOCYTE COMBINATIONS FOR TREATMENT OF SUBCONCUSSIVE- AND CONCUSSIVE-ASSOCIATED NEUROLOGICAL DAMAGE
#105METHODS OF USING ZSCAN4 FOR REJUVENATING HUMAN CELLS
#106TISSUE ARRAY PRINTING
#107METHODS AND COMPOSITIONS INVOLVING TERT ACTIVATING THERAPIES
#108FIBROBLAST GENERATED PATIENT-SPECIFIC VACCINES
#109EXTRACELLULAR VESICLES CONTAINING MIR-142-3P TO TREAT FIBROSING DISEASES
#110CELLULAR SEEDING AND CO-CULTURE OF A THREE DIMENSIONAL FIBROBLAST CONSTRUCT
#111TREATMENT OF AUTISM SPECTRUM DISORDER AND ASSOCIATED NEUROINFLAMMATION USING FIBROBLASTS AND DERIVATIVES THEREOF
#112DIAGNOSIS AND TREATMENT OF CARDIOMYOPATHY
#113FIBROBLAST CELL THERAPY FOR TREATMENT OF OSTEOPOROSIS
#114ENHANCEMENT OF FIBROBLAST THERAPEUTIC ACTIVITY BY RNA
#115DENDRITIC CELL-BASED CANCER VACCINES AND PREPARATION METHOD THEREOF
#116THERAPEUTICALLY ACTIVE CELLS AND EXOSOMES
#117CONDITIONED MEDIUM AND METHODS OF USE THEREOF
#118ENHANCEMENT OF FIBROBLAST THERAPEUTIC ACTIVITY BY T CELL MODULATION
#119SELECTION OF FIBROBLAST DONORS FOR OPTIMIZATION OF ALLOGENEIC FIBROBLAST-MEDIATED REGENERATION
#120PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MYOSITIS, COMPRISING ISOLATED MITOCHONDRIA AS ACTIVE INGREDIENT
#121CONDITIONED MEDIUM AND EXTRACELLULAR MATRIX COMPOSITIONS FROM CELLS CULTURED UNDER HYPOXIC CONDITIONS
#122Multicistronic miRNA delivery for cardiac reprogramming
#123Extracellular Matrices, Uses Thereof, and Methods of Making Extracellular Matrices
#124ALLOGRAFTS CONTAINING VIABLE CELLS AND METHODS THEROF
#125METHODS AND COMPOSITIONS OF CHONDRISOMES
#126Mixed-Cell Gene Therapy
#127MIXED-CELL GENE THERAPY
#128Biodegradable Mesh Implant for Soft Tissue Repair
#129METHOD OF CULTURING ANIMAL CELLS AND ENGINEERING TISSUE AND TISSUE-LIKE STRUCTURES
#130NANOFIBROUS ENCAPSULATION DEVICE FOR SAFE DELIVERY OF THERAPEUTIC AGENTS
#131FIBROBLAST REGENERATIVE CELLS
#132SPALAX FIBROBLAST-DERIVED ANTI-CANCER AGENTS
#133Human cytomegalovirus comprising exogenous antigens
#134System and Method for Seeding an Autologous Tissue Graft
#135FIBROBLASTS FOR TREATMENT OF DEGENERATIVE DISC DISEASE
#136FIBROBLASTS AND MICROVESICLES THEREOF FOR REDUCTION OF TOXICITY ASSOCIATED WITH CANCER IMMUNOTHERAPY
#137COMPOSITIONS AND METHODS FOR REDUCING INFLAMMATION
#138COMPOSITION FOR SKIN REGENERATION AND WOUND HEALING, COMPRISING INDUCED EXOSOMES
#139THERAPEUTIC USES OF GENE EDITED FIBROBLASTS
#140TREATMENT OF CEREBRAL HYPOXIA INCLUDING STROKE, CHRONIC TRAUMATIC ENCEPHALOPATHY, AND TRAUMATIC BRAIN INJURY
#141TREATMENT OF CACHEXIA USING FIBROBLAST CELLS AND PRODUCTS THEREOF
#142METHODS AND COMPOSITIONS FOR TREATMENT OF TYPE 1 DIABETES USING FIBROBLASTS AS FACILITATORS OF ISLET ENGRAFTMENT
#143ANTI-CANCER-ASSOCIATED NON-TUMOR CELL AGENT COMPRISING VIRUS
#144REGENERATIVE ABSCOPAL EFFECTS
#145Interaction of fibroblasts and immune cells for activation and uses thereof
#146DIFFERENTIATION-INDUCED CELL POPULATION FROM WHICH UNDIFFERENTIATED CELLS HAVE BEEN REMOVED, USE OF SAME, AND METHOD FOR PRODUCING SAME
#147METHODS OF CELLULAR REPROGRAMMING
#148COMPOSITION FOR INJECTION WHICH CAN BE USED FOR TREATMENT OF HEART DISEASES AND CONTAINS FIBROBLASTS, AND METHOD FOR PRODUCING FIBROBLAST FOR THERAPY USE
#149CELL-DERIVED PARTICLES PRESENTING HETEROLOGOUS CD24 AND USE THEREOF IN THERAPY
#150METHODS OF ENHANCING FIBROBLAST THERAPEUTIC ACTIVITY
#151Compositions and methods useful in regenerative medicine
#152Systems, devices and methods for the creation of a therapeutic restriction in the gastrointestinal tract
#153Treatment Of Vocal Cords With Autologous Dermal Fibroblast Formulation
#154Mitochondrial augmentation therapy of muscle diseases
#155MITOCHONDRIAL AUGMENTATION THERAPY OF BRAIN DISEASES
#156Mitochondrial augmentation therapy of ocular diseases
#157MITOCHONDRIAL AUGMENTATION THERAPY OF RENAL DISEASES
#158Conditioned medium from cells cultured under hypoxic conditions and uses thereof
#159Methods of improving anemias by combining agents
#160PAIN-REDUCING EFFECTS OF FIBROBLASTS AND TREATMENT OF PAIN
#161ENHANCEMENT OF FIBROBLAST PLASTICITY FOR TREATMENT OF DISC DEGENERATION
#162METHOD OF INDUCING DEDIFFERENTIATION OF SOMATIC CELLS WITH SMALL MOLECULES TO PREPARE REJUVENATED MESENCHYMAL STEM CELLS AND USES THEREOF
#163METHOD OF PREPARING MESENCHYMAL STEM CELLS FROM FIBROBLASTS BY REJUVENATION AND DEDIFFERENTIATION AND USES THEREOF
#164REPROGRAMMING OF CELLS TO A NEW FATE
#165Biotransplant for treating gum recession and restoring gingival tissue volume
#166Liquid delivery composition
#167INTRADISCAL T-REGULATORY CELL ADMINISTRATION FOR TREATMENT OF DISC DEGENERATIVE DISEASE
#168Cell-based therapy for the pulmonary system
#169DE-DIFFERENTIATED FIBROBLAST-CONDITIONED MEDIA FOR STIMULATION OF DISC REGENERATION
#170FIBROBLAST DELIVERY OF TUMOR INHIBITORY AGENTS
#171Placental tissue grafts and improved methods of preparing and using the same
#172THERAPEUTIC EXTRACELLULAR VESICLES
#173Treatment of disc degenerative disease and stimulation of proteoglycan synthesis by fibroblast conditioned media and formulations thereof
#174Multilayered blood product
#175THREE-DIMENSIONAL CELL SPHEROID WITH HIGH PROLIFERATION ACTIVITY, AND PRODUCING METHOD AND USE THEREFOR
#176METHOD AND APPARATUS FOR STIMULATION OF CELLS FOR TISSUE REPAIR
#177CELL SHEET FOR GENE DELIVERY
#178ENGINEERED CELL DEATH-INDUCING ENZYMES AND METHODS OF USE
#179EXTRACELLULAR VESICLES DERIVED FROM CELLS CULTURED UNDER HYPOXIC CONDITIONS AND USES THEREOF
#180ANGIOGENESIS INHIBITOR AND SCREENING METHOD FOR ANGIOGENESIS INHIBITORS
#181METHOD FOR REPROGRAMMING SOMATIC CELLS
#182Cardiomyocyte preparation and preparation method therefor and use thereof
#183ADMINISTRATION OF FIBROBLASTS AND DERIVATIVES THEREOF FOR TREATMENT OF TYPE 2 DIABETES
#184Methods for nuclear reprogramming using synthetic transcription factors
#185Fibroblast therapy for treatment of Duchenne muscular dystrophy
#186Concurrent activation of regenerative and tolerogenic processes by fibroblast-based compositions for the treatment of multiple sclerosis
#187EXTRACELLULAR MATRIX COMPOSITIONS FOR THE TREATMENT OF CANCER
#188COMPOSITIONS AND METHODS FOR TREATING NERVE INJURY
#189Direct reprogramming of cells to cardiac myocyte fate
#190Multilayered blood product
#191Stimulation of angiogenesis by fibroblast derived exosomes
#192HLA G-MODIFIED CELLS AND METHODS
#193Methods and compositions relating to chondrisomes from blood products
#194Methods and compositions relating to chondrisomes from cultured cells
#195Use of gingival fibroblasts in the treatment of alopecia
#196Treatment of chronic obstructive pulmonary disease and lung degeneration using activated fibroblasts and exosome derivatives thereof
#197Treatment of opioid addiction using fibroblasts and products thereof
#198IMPLANTABLE BIOREACTOR AND METHODS FOR MAKING AND USING SAME
#199METHODS TO IMPROVE CELL THERAPY
#200Methods and compositions for repair of cartilage using an in vivo bioreactor
#201Lymphocyte biomarkers for determining the clinical response to cell therapy
#202Treatment agent for lysosomal storage disease
#203EXTRACELLULAR VESICLES FOR AGENT DELIVERY
#204PROCESS FOR PREPARING METABOLIZED CONDITIONED GROWTH MEDIA
#205Non-covalently assembled conductive hydrogel
#206COMPOSITIONS AND METHODS FOR IMMUNE TOLERANCE
#207Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditions
#208DELIVERY OF AUTOLOGOUS CELLS COMPRISING MATRIX METALLOPROTEINASE FOR TREATMENT OF SCLERODERMA
#209Human cytomegalovirus comprising exogenous antigens
#210COMPOSITION FOR PREVENTING OR TREATING BONE DISEASES WHICH HAS EXCELLENT BONE REGENERATION EFFECT
#211HLA G-modified cells and methods
#212METHOD FOR PREPARING A SUPPLEMENT FROM MESENCHYMAL CELL CULTURES OF WHARTON'S JELLY AND USES OF SAME
#213Systems, devices and methods for the creation of a therapeutic restriction in the gastrointestinal tract
#214Reprogramming of cells to a new fate
#215FAT-ASSOCIATED LYMPHOID CLUSTERS AS SITES FOR TRANSPLANTATION, TISSUE REGENERATION, ORGANOGENESIS AND FUNCTION FOR MULTIPLE TISSUES
#216METHODS AND COMPOSITIONS OF CHONDRISOMES
#217Methods of editing DNA methylation
#218METHODS AND COMPOSITIONS HIGH SCALE THERAPEUTIC PRODUCTION OF MEMORY NK CELLS
#219Methods and compositions for stimulation of cell proliferation and provision of biologically active mixtures of FGF2 isoforms
#220IPSC-based vaccine as a prophylactic and therapeutic treatment for cancer
#221METHODS OF USING ZSCAN4 FOR REJUVENATING HUMAN CELLS
#222Methods of using ZSCAN4 for rejuvenating human cells
#223Compositions useful for the treatment of immune-related diseases
#224Preparation of artificial tissues by means of tissue engineering using fibrin and agarose biomaterials
#225METHODS AND COMPOSITIONS FOR MODIFYING GENOMIC DNA
#226LIGHT-SENSITIVE PUMPS FOR SUPPRESSION OF CARDIAC ACTIVITY
#227DIRECT REPROGRAMMING OF A HUMAN SOMATIC CELL TO A SELECTED (PREDETERMINED) DIFFERENTIATED CELL WITH FUNCTIONALIZED NANOPARTICLES
#228Composition for injection which can be used for treatment of heart diseases and contains fibroblasts, and method for producing fibroblast for therapy use
#229Allografts containing viable cells and methods thereof
#230Extracellular matrix compositions for the treatment of cancer
#231PROCESS FOR PREPARING METABOLIZED CONDITIONED GROWTH MEDIA
#232Compositions of Ascorbic Acid and Bone Morphogenetic Protein 4 (BMP-4) for Cell Growth and Uses Related Thereto
#233Platelet lysate gel
#234Treatment of vocal cords with autologous dermal fibroblast formulation
#235Human tissue derived compositions and uses thereof
#236NOVEL PEPTIDE OR SALT THEREOF, COMPOSITION FOR ENHANCING PROLIFERATION OF FIBROBLAST CELLS AND COMPOSITION FOR ENHANCING ELASTIN PRODUCTION IN FIBROBLAST CELLS AND CHONDROCYTES CONTAINING THE SAME
#237DEVICE AND SYSTEM FOR MICRONIZING TISSUE
#238Cell derived extracellular vesicles for the treatment of diseases
#239CELLULAR BLEND FOR THE REGENERATION OF CHONDROCYTES OR CARTILAGE TYPE CELLS
#240Method using expression of LIN28 for preparing stem cells having excellent renewal ability and therapeutic capacity
#241METHOD OF TREATMENT OF OSTEOCHONDRAL DEFECTS
#242Method for the cryopreservation of cells for therapeutic purposes
#243Cardiac cell culture material
#2443-DIMENSIONAL CARDIAC FIBROBLAST DERIVED EXTRACELLULAR MATRIX
#245Direct reprogramming of cells to cardiac myocyte fate
#246Methods and compositions for repair of cartilage using an in vivo bioreactor
#247Generation of therapeutic cells using extracellular components of target organs
#248Human cytomegalovirus comprising exogenous antigens
#249Diagnosis and treatment of parkinson's disease based on identification and amelioration of liver dysfunction
#250INDUCED PLURIPOTENT STEM CELL DERIVED GLIAL ENRICHED PROGENITOR CELLS FOR THE TREATMENT OF WHITE MATTER STROKE
#251Biodegradable hydrogel for tissue expansion
#252FIBROBLASTS FOR TREATMENT OF DEGENERATIVE DISC DISEASE
#253Cellular seeding and co-culture of a three dimensional fibroblast construct
#254SCAFFOLD FOR GROWING NEURONAL CELLS AND TISSUE
#255Vascular cast-based scaffolds and methods of making the same
#256ORAL TISSUE REGENERATION AND REPAIR
#257Induction of osteogenesis by delivering BMP encoding RNA
#258fibroblast-derived anti-cancer agents
#259Methods of enhancing fibroblast therapeutic activity
#260CELL LINES MUTANT FOR PATCHED 1 AND PATCHED 2 AND METHODS OF USE THEREOF
#261Sulfated alginate hydrogels for cell culture and therapy
#262ENGINEERED MODEL OF FIBROTIC DISEASES
#263Cell structure and method for producing cell structure
#264Methods for high scale therapeutic production of memory NK cells
#265Extracellular matrix compositions for the treatment of cancer or immunological diseases
#266Methods for modifying genomic DNA
#267Cell culture method
#268Methods of inducing vascular morphogensis
#269Placental tissue grafts and improved methods of preparing and using the same
#270METHODS AND DEVICES FOR STIMULATING CELL PROLIFERATION
#271Methods to Accelerate Wound Healing in Diabetic Subjects
#272Methods and compositions for stimulation of cell proliferation and provision of biologically active mixtures of FGF2 isoforms
#273Extracellular vesicles for agent delivery
#274PRODUCTION OF ARTIFICIAL TISSUES COMPRISING MAGNETIC PARTICLES
#275METHOD FOR TREATING CANCER
#276Core-shell capsules for encapsulation of particles, colloids, and cells
#277WOUND HEALING FORMULATION
#278Pouch-like structure with paracrine activity and method for its preparation
#279Method for producing nervous system cells
#280Human tissue derived compositions and uses thereof
#281DIFFERENTIATION-INDUCED CELL POPULATION FROM WHICH UNDIFFERENTIATED CELLS HAVE BEEN REMOVED, USE OF SAME, AND METHOD FOR PRODUCING SAME
#282Platelet lysate gel
#283Tissue Engineering Methods and Compositions
#284Methods and compositions for wound healing
#285HLA G-modified cells and methods
#286Method for preparing a biological tissue construct and use of autologous cells obtained specifically
#287Targeting breast cancer therapy based on stromal subtypes and CD146 composition
#288TOPICAL FORMULATION FOR SKIN CARE
#289Devices for wound healing
#290A COMBINATION OF KYNURENINE AND ANTIGEN PRESENTING CELLS (APC) AS THERAPEUTICS AND METHODS FOR THEIR USE IN IMMUNE MODULATION
#291DEVICE AND METHOD FOR ASSESSING CELL CONTRACTION
#292POLYVALENT ANTI-TUMOR FIBROBLAST VACCINE
#293Crosslinked peptide hydrogels
#294Crosslinked peptide hydrogels
#295Crosslinked peptide hydrogels
#296Topical formulation for skin care
#297Method and composition for inducing human pluripotent stem cells
#298Reprogramming of cells to a new fate
#299METHODS AND COMPOSITIONS OF CHONDRISOMES
#300TOPICAL SKIN COMPOSITIONS HAVING PROTEINS AND METHODS OF USE